Regencell Bioscience Holdings (RGC) Prepaid Assets (2021 - 2025)
Regencell Bioscience Holdings (RGC) posted Prepaid Assets of $5798.0 for Q2 2025, down 96.2% on a QoQ basis from $152778.0 in Q2 2024, and down 96.2% year-over-year from $152778.0 in Q2 2024.
Regencell Bioscience Holdings (RGC) Prepaid Assets (2021 - 2025) Analysis & Trends
Regencell Bioscience Holdings' Prepaid Assets history runs 5 years deep, the most recent figure standing at $5798.0 for Q2 2025.
- Quarterly Prepaid Assets fell 96.2% year-over-year to $5798.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $5798.0 (down 96.2% YoY) and the FY2025 annual result came in at $5798.0, down 96.2% from the prior year.
- Prepaid Assets was $5798.0 for Q2 2025 at Regencell Bioscience Holdings, down from $152778.0 in the prior quarter.
- Across five years, Prepaid Assets topped out at $152778.0 in Q2 2024 and bottomed at $5798.0 in Q2 2025.
- A 5-year average of $50031.6 and a median of $27598.0 in 2022 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2022 — Prepaid Assets jumped 271.14% — and 2025, when it tumbled 96.2%.
- Regencell Bioscience Holdings' Prepaid Assets stood at $7436.0 in 2021, then soared by 271.14% to $27598.0 in 2022, then surged by 104.9% to $56548.0 in 2023, then soared by 170.17% to $152778.0 in 2024, then tumbled by 96.2% to $5798.0 in 2025.
- Business Quant data shows RGC's Prepaid Assets at $5798.0 in Q2 2025, $152778.0 in Q2 2024, and $56548.0 in Q2 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 88.79 Bn | 86.92 Bn | - |
| 2 | Teva Pharmaceutical Industries | 36.00 Bn | 32.26 Bn | 1.97 Bn |
| 3 | Zoetis | 32.11 Bn | 30.17 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.45 Bn | 23.38 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.26 Bn | 21.10 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - |
| 7 | Viatris | 20.21 Bn | 18.41 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.48 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn |
| 10 | Regencell Bioscience Holdings | 2.88 Bn | 2.88 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 5,798.00 |
| Jun 30, 2024 | 152,778.00 |
| Jun 30, 2023 | 56,548.00 |
| Jun 30, 2022 | 27,598.00 |
| Jun 30, 2021 | 7,436.00 |